Application 210665
- Type
- ANDA
- Sponsor
- FRESENIUS KABI USA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | SOLUTION;INTRAVENOUS | 10MG/ML (10MG/ML) | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 51662-1576 | PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1576 | PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 63323-751 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-751 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-751 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-751 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | Fresenius Kabi USA, LLC | ANDA | Current |